HSPA5 and COVID-19: These pathophysiological human health and disease conditions—older age, obesity, diabetes, some types of cancer—likely create environments for the induction and activation of GRP78 in intracellular, extracellular, and circulation areas, which potentially makes patients more vulnerable to COVID-19 (Figure 4).